The Must-Know Finance Concepts for Life Sciences Valuations - Part 2

This is part 2 of the whitepaper where we go into more detail on the key finance concepts and most common methodologies used to evaluate life sciences assets.

In this whitepaper, you’ll learn:

  • Valuation methodology most used by big pharma
  • The 3 fundamental concepts in valuation
  • Cash flow examples for different situations
  • And more

VIEW THE
WHITEPAPER

WHITEPAPER AUTHOR:

Company team

Jeff Karan

Co-Founder and Managing Partner of WaveEdge Capital

Jeff brings over 30 years of investment banking and corporate advisory experience to WaveEdge Capital. In addition to his extensive knowledge of capital raising and merger & acquisitions, Jeff has advised clients on corporate strategy, business valuation, and a wide range of strategic partnership structures. Learn More

Company team

John Selig

Co-Founder and Managing Partner of WaveEdge Capital

John advises life sciences companies on M&A, licensing and financial strategy. He teaches the valuation and finance module at BIO’s Executive Management course for BD professionals and at Stanford Medical School’s Entrepreneurship program. Learn More

Sponsored by